Interestingly, breast cancer cells that metastasize to bone often maintain high levels of both Runx2 and SNAI2, even in the context of elevated ERα expression, highlighting a distinct molecular signature of bone tropism in ER+ disease [115]. Here, RUNX2 is linked to breast carcinoma.